HIV | HIV Indicator Diseases Across Europe Study
HIV research study
What is the primary objective of this study?
The purpose of this non-interventional study is to implement a survey initiative to assess HIV prevalence for one or more diseases and/or conditions within a specific segment of the population not yet diagnosed with HIV, who presents for care with the specific disease/condition. The list of diseases below is not indicative of the most important indicator diseases for HIV but rather a list of diseases suggested for surveillance. This study will enrol patients presenting with the following diseases/conditions: 1. Presenting for care of malignant lymphoma, irrespective of type 2. Presenting for care of cervical or anal dysplasia or cancer, (Cervical CIN II and above) 3. Presenting for care of Hepatitis B or C virus infection (acute or chronic - and irrespective of time of diagnosis relative to time of survey), 4. Presenting with ongoing mononucleosis-like illness 5. Presenting with unexplained leukocytopenia or thrombocytopenia lasting at least 4 weeks 6. Presenting with seborrheic dermatitis / exanthema 7. Presenting with pneumonia, admitted to hospital for at least 24h 8. Presenting with unexplained lymphadenopathy 9. Presenting with peripheral neuropathy of unknown cause (diagnosed by neurologist) 10. Presenting with primary lung cancer 11. Presenting with severe or recalcitrant psoriasis (newly diagnosed)
Who is eligible to participate?
Inclusion Criteria: - HIV status unknown - Presenting for care with 1 of the 11 indicator diseases surveyed. Exclusion Criteria: - Known HIV positive
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
Start Date: February 2012
Completed Date: June 2014
Primary Outcome: Prevalence of HIV
Study sponsors, principal investigator, and references
Principal Investigator: Jens D Lundgren, Prof.
Lead Sponsor: Jesper Grarup